Back to Rockefeller Capital Management L.P. Rockefeller Capital Management L.P.

REGNREGN
Showing 8 of 31 quarters

Position history for Rockefeller Capital Management L.P.Rockefeller Capital Management L.P.'s holdings in Regeneron Pharmaceuticals, Inc.

Yes. Rockefeller Capital Management holds 21,563 shares of REGN (Regeneron Pharmaceuticals), worth $13.4M, as of its Q2 2026 13F filing. It reduced the position by 6,957 shares (-24.4%) from Q1 2026. Rockefeller Capital Management has held REGN in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$13.4M

Current Shares

21,563

Total Value Change

-$89.6M

Total Shares Change

-76,441

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
21,563
-24.4%
$13.4M0.0%$622.81
0
2026-Q1
Increased
28,520
+5.4%
$22M0.0%$770.59
30
2025-Q4
Increased
27,053
+4.7%
$20.9M0.0%$768.90
30
2025-Q3
Decreased
25,842
-12.8%
$14.5M0.0%$559.40
0
2025-Q2
Decreased
29,620
-56.2%
$15.6M0.0%$521.53
0
2025-Q1
Decreased
67,608
-28.6%
$42.9M0.1%$629.11
0
2024-Q4
Decreased
94,744
-3.3%
$67.5M0.2%$705.67
0
2024-Q3
Decreased
98,004
-1.1%
$103M0.3%$1,041.41
0

Other major holders of REGN: FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used